NeuroOne Medical Technologies Corp (NASDAQ: NMTC) started the day on Wednesday, with a price decrease of -5.49% at $0.67, before settling in for the price of $0.71 at the close. Taking a more long-term approach, NMTC posted a 52-week range of $0.40-$1.39.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 23.14%. Meanwhile, its Annual Earning per share during the time was 23.14%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 80.48%. This publicly-traded company’s shares outstanding now amounts to $49.82 million, simultaneously with a float of $46.34 million. The organization now has a market capitalization sitting at $33.40 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7426, while the 200-day Moving Average is $0.7537.
NeuroOne Medical Technologies Corp (NMTC) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. NeuroOne Medical Technologies Corp’s current insider ownership accounts for 7.32%, in contrast to 41.94% institutional ownership. According to the most recent insider trade that took place on Sep 05 ’25, this organization’s Business Development Director sold 30,000 shares at the rate of 0.74, making the entire transaction reach 22,203 in total value, affecting insider ownership by 231,238.
NeuroOne Medical Technologies Corp (NMTC) Earnings and Revenue Records
NeuroOne Medical Technologies Corp’s EPS increase for this current 12-month fiscal period is 80.48% and is forecasted to reach -0.17 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.65% through the next 5 years, which can be compared against the 23.14% growth it accomplished over the previous five years trading on the market.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Trading Performance Indicators
Let’s observe the current performance indicators for NeuroOne Medical Technologies Corp (NMTC). It’s Quick Ratio in the last reported quarter now stands at 5.80. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.47.
In the same vein, NMTC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.16, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.17 at the market close of one year from today.
Technical Analysis of NeuroOne Medical Technologies Corp (NMTC)
If we take a close look at the recent performances of NeuroOne Medical Technologies Corp (NASDAQ: NMTC), its last 5-days Average volume was 0.42 million that shows progress from its year to date volume of 0.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 59.66% While, its Average True Range was 50.45.
Raw Stochastic average of NeuroOne Medical Technologies Corp (NMTC) in the period of the previous 100 days is set at 19.92%, which indicates a major fall in contrast to 43.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0585 that was lower than 0.0630 volatility it exhibited in the past 100-days period.
